ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 125 filers reported holding ANI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,869,000 | -53.5% | 125,399 | -50.8% | 0.30% | -59.0% |
| Q1 2017 | $12,620,000 | -22.1% | 254,889 | -4.6% | 0.72% | -37.5% |
| Q4 2016 | $16,192,000 | +2011.1% | 267,100 | +2210.4% | 1.15% | +2202.0% |
| Q3 2016 | $767,000 | -79.5% | 11,561 | -82.8% | 0.05% | -80.8% |
| Q2 2016 | $3,749,000 | -2.3% | 67,161 | -41.1% | 0.26% | -22.8% |
| Q1 2016 | $3,839,000 | +564.2% | 114,060 | +791.1% | 0.34% | +683.7% |
| Q4 2015 | $578,000 | -62.0% | 12,800 | -66.8% | 0.04% | -29.5% |
| Q3 2015 | $1,522,000 | -92.5% | 38,512 | -88.2% | 0.06% | -95.0% |
| Q2 2015 | $20,300,000 | +5.4% | 327,157 | +6.3% | 1.22% | -18.3% |
| Q1 2015 | $19,252,000 | +9.2% | 307,784 | -1.5% | 1.50% | +1.2% |
| Q4 2014 | $17,622,000 | +1148.9% | 312,500 | +594.4% | 1.48% | +898.6% |
| Q1 2014 | $1,411,000 | – | 45,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |